AVITA Medical, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| RCEL | ARX.AX | INMD | IART | BVS | AORT | |
|---|---|---|---|---|---|---|
| Market cap | 511.05M | 171.82M | 817.13M | 1.15B | 781.98M | 1.29B |
| P/E (TTM) | — | 49.0 | 11.7 | 87.2 | 14.1 | — |
| Forward P/E | -38.3 | 16.8 | 10.3 | 6.2 | 12.5 | 35.3 |
| Price/book | -18.1 | 2.1 | 1.3 | 1.1 | 3.3 | 2.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +338.00% | −38.22% | −1.66% | +32.09% | +52.67% | −44.32% |
| Today | +6.46% | +1.03% | +0.85% | +8.73% | +4.34% | +11.56% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 20 min.
Latest news
All RCEL news ›AVITA Medical Q3 2026 Earnings Preview
AVITA Medical (RCEL) is scheduled to announce Q3 earnings results on Thursday, November 5th, after market close. The consensus EPS Estimate is -$0.20 and the co - AVITA Medical (RCEL) is scheduled to announce Q3 earnings results on…
Avita Medical (RCEL) Projected to Post Earnings on Thursday
Posted by Kim Johansen on Nov 4th, 2026 Shares of RCEL opened at $15.33 on Wednesday. The firm’s 50-day moving average price is $12.42 and its 200-day moving average price is $6.66. The firm has a market capitalization of $471.86 million,…
AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller Wounds
VALENCIA, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today…
Contrasting Nano-X Imaging (NASDAQ:NNOX) and Avita Medical (NASDAQ:RCEL)
Posted by Sarita Garza on Oct 26th, 2026 Nano-X Imaging (NASDAQ:NNOX – Get Free Report) and Avita Medical (NASDAQ:RCEL – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two…
How Avita Medical Inc. (RCEL) Affects Rotational Strategy Timing
Stock Traders Daily What you're reading is a snapshot. Members see the RCEL analysis update in real time as the market moves, and get the same coverage on every other stock we follow. Proprietary Signals for RCEL Blue = Current Price
Avita Medical (NASDAQ:RCEL) Price Target Raised to $15.00
Posted by Sarita Garza on Oct 15th, 2026 Avita Medical (NASDAQ:RCEL – Free Report) had its price objective increased by BTIG Research from $11.00 to $15.00 in a report issued on Monday,Benzinga reports. The brokerage currently has a buy…
Contrasting Anteris Technologies Global (NASDAQ:AVR) & Avita Medical (NASDAQ:RCEL)
Posted by Defense World Staff on Oct 11th, 2026 Anteris Technologies Global (NASDAQ:AVR – Get Free Report) and Avita Medical (NASDAQ:RCEL – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will…
Avita Medical Inc. (NASDAQ:RCEL) Receives Consensus Rating of “Moderate Buy” from Analysts
Posted by Defense World Staff on Oct 8th, 2026 Check Out Our Latest Report on RCEL Avita Medical is a regenerative medicine company focused on developing and commercializing technologies that use a patient’s own cells to support skin…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- themarketsdaily.com3
- defenseworld.net2
- news.stocktradersdaily.com1
- seekingalpha.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.